Pharming Group(PHAR) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

PHAR Pharming Group

Watchlist

7.960
0.0000.00%

Trading Mar 10 15:50 ET

539.97MMarket Cap-29.48P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: PHAR to Report Financial Results Pre-market on March 13
Moomoo NewsMar 7 20:00 ET
Pharming Group Shareholders Approved The Appointment Of Mr. Fabrice Chouraqui As Executive Director And CEO For A Term Of 4-Years
BenzingaMar 4 09:40 ET
Press Release: Pharming Group Reports on Results of the 2025 Extraordinary General Meeting of Shareholders
Dow JonesMar 4 09:15 ET
Pharming Group to Report Fourth Quarter and Full Year 2024 Financial Results on March 13
GlobeNewswireFeb 27 02:00 ET
Abliva Applies to Delist From Nasdaq Stockholm
MT NewswiresFeb 25 09:56 ET
Pharming Group to Participate in February Investor Conference
GlobeNewswireFeb 10 02:00 ET

Comments

Stock_Drift

Dec 11, 2024 04:16

Pre Market Ticks 5:14am 12/11

$Sportsman's Warehouse (SPWH.US)$ $Pharming Group (PHAR.US)$ $BioXcel Therapeutics (BTAI.US)$ $Gaxos.ai (GXAI.US)$ $Rigetti Computing (RGTI.US)$ $Quantum (QMCO.US)$ $MIND Technology (MIND.US)$ $Stitch Fix (SFIX.US)$ $Frequency Electronics (FEIM.US)$ $CleanCore Solutions (ZONE.US)$ $Silexion Therapeutics (SLXN.US)$ $SEALSQ Corp (LAES.US)$
📊⚡️📊

Teddy123

Oct 10, 2024 00:28

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

$Pharming Group (PHAR.US)$
Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces the start of a Phase II, proof of concept, clinical trial evaluating leniolisib in primary immunodeficiencies (PIDs) with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytes.
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation | PHARM Stock News

Mooers Radar

Jul 25, 2023 19:38

Columns US Top Gap Ups and Downs on 7/25: LOGI, UL, RTX, SPOT and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Logitech International (LOGI.US)$ - up 6.9%
2. $F5 Inc (FFIV.US)$ - up 5.1%
3. $Unilever (UL.US)$ - up 3.9%
4. $Packaging Corp of America (PKG.US)$ - up 3.4%
5. $Rio Tinto (RIO.US)$ - up 2.5%
6. $GE Aerospace (GE.US)$ - up 2.5%
7. $ASE Technology (ASX.US)$ - up 2.4%
8. $Datadog (DDOG.US)$ - up 2.4...

+16

Mooers Radar

Jul 11, 2023 19:41

Columns US Top Gap Ups and Downs on 7/11: HPQ, CRM, TM, PHAR and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Zillow-A (ZG.US)$ - up 3.4%
2. $Newell Brands (NWL.US)$ - up 3.3%
3. $Etsy Inc (ETSY.US)$ - up 3.3%
4. $Zillow-C (Z.US)$ - up 3.0%
5. $Pharming Group (PHAR.US)$ - up 2.8%
6. $HP Inc (HPQ.US)$ - up 2.4%
7. $Salesforce (CRM.US)$ - up 2.1%
8. $SK Telecom (SKM.US)$ - up 1.9%
9. $Procore Technologies (PCOR.US)$ - up 1....

+15

Mooers Radar

Jun 23, 2023 19:20

Columns US Top Gap Ups and Downs on 6/23: KMX, PHAR, HMC, SONY and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $CarMax (KMX.US)$ - up 6.1%
2. $GlaxoSmithKline (GSK.US)$ - up 2.6%
3. $Fresenius Medical Care (FMS.US)$ - up 1.4%
Gap Downs
1. $Pharming Group (PHAR.US)$ - down 4.2%
2. $Woodside Energy (WDS.US)$ - down 3.6%
3. $Sasol (SSL.US)$ - down 3.3%
4. $ING Groep (ING.US)$ - down 2.8%
5. $Banco Santander (SAN.US)$ - down 2....

+10

PHAR Pharming Group

Trade Overview

Capital Trend

News

Comments

Trending Stocks